Trials / Unknown
UnknownNCT01398189
F-18 Altanserin PET Study of Patients Receiving Clozapine
Validation of Molecular Imaging Technologies for Early Clinical Trials
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 12 (estimated)
- Sponsor
- Seoul National University Bundang Hospital · Academic / Other
- Sex
- All
- Age
- 19 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
To examine the feasibility of molecular imaging markers in clinical psychopharmacology
Detailed description
Clinical evaluation of patients with psychiatric disorders is mainly dependent on patients' reports and clinicians' observations. In order to develop objective and quantifiable measures of psychopathology, molecular imaging techniques will be used in patients receiving clozapine.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | clozapine | C-11 clozapine |
Timeline
- Start date
- 2011-07-01
- Primary completion
- 2015-07-01
- Completion
- 2015-07-01
- First posted
- 2011-07-20
- Last updated
- 2013-11-21
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01398189. Inclusion in this directory is not an endorsement.